Nuvelo
Alfimeprase thrombolytic enzyme and RNAi-based therapeutics platform for cardiovascular and oncology diseases
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 34 pending
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextFounders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 34- PendingAntibodies To LRP6USPTOApplication PCTUS2008083486
- PendingAntibodes To CLL-1USPTOApplication PCTUS2008078702
- PendingAntibodies To IREM-1USPTOApplication PCTUS2008078381
Show all 34 patent records
- Antibodies To LRP6Application PCTUS2008083486Pending
- Antibodes To CLL-1Application PCTUS2008078702Pending
- Antibodies To IREM-1Application PCTUS2008078381Pending
- Methods For Treating CancerApplication PCTUS2007078225Pending
- Antibodies To Ntb-aApplication PCTUS2007076190Pending
- Stem Cell Factor-like Protein SCFA1 And Uses ThereofApplication PCTUS2006039266Pending
- Stem Cell Factor-like Proteins And Uses ThereofApplication PCTUS2006001992Pending
- Methods Of Therapy And Diagnosis Using Targeting Of Cells That Express STEAP2 PolypeptidesApplication PCTUS2005005204Pending
- HC1Q/TNF7 And Uses ThereofApplication PCTUS2005004621Pending
- Methods And Materials Relating To Insulin Growth Factor-like (igfl) Polypeptides And PolynucleotidesApplication PCTUS2005003374Pending
- Methods And Materials Relating To Novel C1Q Domain-containing Polypeptides And PolynucleotidesApplication PCTUS2005001193Pending
- Methods Of Therapy And Diagnosis Using Targeting Of Cells That Express Bclp PolypeptidesApplication PCTUS2004043278Pending
- Methods Of Therapy And Diagnosis Using Targeting Of Cells That Express A Human Transporter-like ProteinApplication PCTUS2004012170Pending
- Methods Of Therapy And Diagnosis Using Targeting Of Cells That Express Killer Cell Immunoglobulin-like Receptor-like ProteinApplication PCTUS2004011171Pending
- Novel Nucleic Acids And PolypeptidesApplication PCTUS2004007412Pending
- Novel Nucleic Acids And PolypeptidesApplication PCTUS2003040759Pending
- Methods Of Therapy And Diagnosis Using Targeting Of Cells That Express LY-9Application PCTUS2003038364Pending
- Methods Of Immunotherapy And Diagnosis Using Targeting Of Cells That Express LaxApplication PCTUS2003037907Pending
- Methods Of Therapy And Diagnosis Using Targeting Of Cells That Expres P2710Application PCTUS2003037616Pending
- Methods Of Therapy And DiagnosisApplication PCTUS2003036971Pending
- Materials And Methods Relating To Therapy And Diagnosis Using Targeting Of Cells That Express Dcal-hy PolypeptidesApplication PCTUS2003033582Pending
- Novel Nucleic Acids And PolypeptidesApplication PCTUS2003030720Pending
- Methods And Materials Relating To And PolynucleotidesApplication PCTUS2003024922Pending
- Methods And Materials Relating To Novel Polypeptides And PolynucleotidesApplication PCTUS2003021703Pending
- Methods And Materials Relating To Neurotrimin-like Polypeptides And PolynucleotidesApplication PCTUS2003015411Pending
- Methods Of Therapy And DiagnosisApplication PCTUS2003004515Pending
- Methods And Meterials Relating To Novel Polypeptides And PolynucleotidesApplication PCTUS2002038526Pending
- Methods And Materials Ralating To Prokineticin-like Polypeptides And PolynucleotidesApplication PCTUS2002035465Pending
- Novel Nucleic Acids And PolypeptidesApplication PCTUS2002030474Pending
- Novel Nucleic Acids And PolypeptidesApplication PCTUS2002029964Pending
- Novel Nucleic Acids And Sereted PolypeptidesApplication PCTUS2002029636Pending
- Novel Nucleic Acids And PolypeptidesApplication PCTUS2002029001Pending
- Methods And Materials Relating To Stem Cell Growth Factor-like Polypeptides And Polypeptides And PolynucleotidesApplication PCTUS2002027746Pending
- Novel Nucleic Acids And Secreted PolypeptidesApplication PCTUS2002022858Pending
Related companies, and why
- SENSEION, LLCSimilar federal contract value in Biotech · null in contracts
- Kalaris TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Omega TherapeuticsSimilar federal contract value in Biotech · null in contracts
- AstronauTxSimilar federal contract value in Biotech · null in contracts
- Socrates Biosciences IncSimilar federal contract value in Biotech · null in contracts
- STONESTABLE, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .